<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04630431</url>
  </required_header>
  <id_info>
    <org_study_id>19-004014</org_study_id>
    <secondary_id>NCI-2020-08521</secondary_id>
    <secondary_id>19-004014</secondary_id>
    <secondary_id>P30CA015083</secondary_id>
    <nct_id>NCT04630431</nct_id>
  </id_info>
  <brief_title>Understanding the Challenges, Behavioral Patterns, and Preferences Towards Participation in Clinical Trials in Minority Patient Populations</brief_title>
  <official_title>Understanding the Challenges, Behavioral Patterns, and Preferences Towards Participation in Clinical Trials in Minority Patient Populations</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study investigates the challenges, behavioral patterns, and preferences towards&#xD;
      participation in clinical trials in minority patient populations. Learning more about&#xD;
      patient's understanding of clinical trials, may help identify barriers that limit patient's&#xD;
      participation. Information gathered from this study may help in developing future educational&#xD;
      materials that may aid minority patients in overcoming barriers to participating in clinical&#xD;
      trials.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      PRIMARY OBJECTIVES:&#xD;
&#xD;
      I. To understand and document patient preferences, understanding, and attitudes regarding&#xD;
      clinical trials.&#xD;
&#xD;
      II. To compare patient attitudes regarding clinical trials among cancer patients belonging to&#xD;
      different racial/ethnic groups.&#xD;
&#xD;
      OUTLINE:&#xD;
&#xD;
      Patients complete a questionnaire about their preferences, understanding, and attitudes&#xD;
      regarding clinical trials. Patients also have their medical records reviewed.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 15, 2019</start_date>
  <completion_date type="Anticipated">October 15, 2022</completion_date>
  <primary_completion_date type="Anticipated">October 15, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Documentation of patient preferences regarding clinical trials</measure>
    <time_frame>Baseline</time_frame>
    <description>Collection of questionnaire to document patient preferences towards clinical trials. To be summarized using Means and/or medians.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Documentation of patient understanding regarding clinical trials</measure>
    <time_frame>Baseline</time_frame>
    <description>Collection of questionnaire to document patient understanding towards clinical trials. To be summarized using Means and/or medians.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Documentation of patient preferences, understanding, and attitudes regarding clinical trials</measure>
    <time_frame>Baseline</time_frame>
    <description>Collection of questionnaire to document patient attitudes regarding clinical trials. To be summarized using Means and/or medians.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Comparison of patient attitudes regarding clinical trials among cancer patients belonging to different racial/ethnic groups</measure>
    <time_frame>Baseline</time_frame>
    <description>Collection of questionnaire to document patient attitudes regarding clinical trials among cancer patients belonging to different racial/ethnic groups. To be summarized using Means and/or medians.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Association of baseline patient characteristics (socioeconomic status, level of education, social support, among others) with the patient's preferences and understanding regarding clinical trials</measure>
    <time_frame>Baseline</time_frame>
    <description>Will be obtained from the Epic electronic medical record and from the baseline survey.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Association of disease state (newly diagnosed versus previously treated) with patients understanding and behavior towards clinical trial participation</measure>
    <time_frame>Baseline</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Hematopoietic and Lymphoid Cell Neoplasm</condition>
  <condition>Malignant Solid Neoplasm</condition>
  <arm_group>
    <arm_group_label>Observational (questionnaire, medical record review)</arm_group_label>
    <description>Patients complete a questionnaire about their preferences, understanding, and attitudes regarding clinical trials. Patients also have their medical records reviewed.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Electronic Health Record Review</intervention_name>
    <description>Review of medical record</description>
    <arm_group_label>Observational (questionnaire, medical record review)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Questionnaire Administration</intervention_name>
    <description>Complete questionnaire</description>
    <arm_group_label>Observational (questionnaire, medical record review)</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with cancer diagnosis who present for their initial visit to Mayo Clinic in&#xD;
        Florida, Arizona, Rochester, or Mayo Clinic Cancer Center at St. Vincent's&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Subjects with any cancer diagnosis may be included&#xD;
&#xD;
          -  Subjects must be identified as new patients to hematology oncology at Mayo Clinic&#xD;
             Florida, Arizona, Rochester, and Mayo Clinic Cancer Center at St. Vincent's&#xD;
&#xD;
          -  Subjects must be willing to provide informed consent for the study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients reported to have an estimated life-expectancy of &lt; 6 months, as assessed by&#xD;
             their clinician&#xD;
&#xD;
          -  Patients not willing to complete the Clinical Trials Study survey&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sikander Ailawadhi</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mayo Clinic in Arizona</name>
      <address>
        <city>Scottsdale</city>
        <state>Arizona</state>
        <zip>85259</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Referral Office</last_name>
      <phone>855-776-0015</phone>
      <email>mayocliniccancerstudies@mayo.edu</email>
    </contact>
    <investigator>
      <last_name>Cassandra N. Moore, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cancer Specialists of North Florida-Saint Vincent's</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32204</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Referral Office</last_name>
      <phone>855-776-0015</phone>
      <email>mayocliniccancerstudies@mayo.edu</email>
    </contact>
    <investigator>
      <last_name>Nilesh Verma, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic in Florida</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32224-9980</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Referral Office</last_name>
      <phone>855-776-0015</phone>
      <email>mayocliniccancerstudies@mayo.edu</email>
    </contact>
    <investigator>
      <last_name>Sikander Ailawadhi, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic in Rochester</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Referral Office</last_name>
      <phone>855-776-0015</phone>
      <email>mayocliniccancerstudies@mayo.edu</email>
    </contact>
    <investigator>
      <last_name>Rahma M. Warsame, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>November 10, 2020</study_first_submitted>
  <study_first_submitted_qc>November 10, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 16, 2020</study_first_posted>
  <last_update_submitted>November 3, 2021</last_update_submitted>
  <last_update_submitted_qc>November 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

